Sign in to fuzzto save your conversations, follow your research and come back anytime.
Caplin Point Laboratories
CAPLIPOINT
NSE
BSE
NSEBSESectorHealthcare
2,845.00
Loading chart…
About the company
Caplin Point Laboratories Limited is an Indian pharmaceutical company founded in 1990. It develops, produces, and markets generic formulations and branded products globally. The company has manufacturing facilities in India and serves markets in Latin America, Africa, the USA, and the European Union. Caplin Point specializes in various pharmaceutical formulations, including injectables, tablets, capsules, and syrups. The company has expanded through acquisitions, partnerships, and investments in subsidiaries. It has a strong presence in emerging markets and has entered regulated markets like the USA. Caplin Point has invested in research and development, including API development and clinical research. The company has also ventured into e-commerce and has been expanding its product portfolio and manufacturing capabilities.
In the news
3 Pharma Stocks in Focus: GMP Clearances & GSK's mRNA Flu Vaccine
Caplin Point shares fall 2.38% after USFDA issues 10 observations
Caplin Point Labs Q1 profit jumps 17.5% to ₹179.6 cr
Caplin Point Lab hits 52-week high at ₹2,405.4, stock surges 20% in 5 days
ICICI Securities recommends Caplin Point buy amid ₹27,048 cr FII outflows
Caplin Point Labs Q4 profit jumps 19.32% to ₹170.11 cr
Caplin Point shares surge 9% on strong Q4 results, profit up 19%
Caplin Point Acquires 10 ANDAs Worth $473M to Strengthen US Portfolio